Theres no single perfect number for everyone, but many patients taking GLP-1 medications benefit from aiming for higher protein intake than they were eating previously
Direct-to-consumer peptide vendors operate in a legally gray area, selling research-grade tirzepatide without prescriptions at deeply discounted prices, sometimes $50 to $100 per month
Gastrointestinal symptoms, including stomach pain, typically emerge during the initial weeks of treatment or following dose escalation
Universally applied pharmacologic therapy with non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids have proven effective in relieving stiffness and pain, but do not moderate disease progression
ECG interpretation is also essential in identifying silent cardiac risks that may impact insurability/takaful coverage
GIP receptor activation Tirzepatide proved that adding a second receptor, GIP, produced meaningfully better outcomes than GLP-1 alone